TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 26398632

Group type: EXPERIMENTAL
Intervention: Decoupling (DC)
Number of subjects: 105

Group type: COMPARATOR
Intervention: Progressive Muscle Relaxation (PMR)
Number of subjects: 105
Study: 24750327

Group type: EXPERIMENTAL
Intervention: P/R + V (Peg‐IFNα2a and Ribavirin + E1E2MF59 vaccine)
Number of subjects: 78

Group type: COMPARATOR
Intervention: P/R (Peg‐IFNα2a and Ribavirin)
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: P/R + V
Number of subjects: 78
Study: 22134600

Group type: EXPERIMENTAL
Intervention: CIDR protocol (controlled intravaginal progesterone releasing insert, 1.38 g of progesterone)
Number of subjects: 191

Group type: COMPARATOR
Intervention: PGF2alpha analogue cloprostenol (0.5 mg per animal i.m.)
Number of subjects: 191

Group type: EXPERIMENTAL
Intervention: CIDR protocol
Number of subjects: 191

Group type: COMPARATOR
Intervention: PGF2alpha protocol
Number of subjects: 191
Study: 19554089

Group type: EXPERIMENTAL
Intervention: Vitamin E and allopurinol treatment for 3-5 days before surgery
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 60
Study: 17824352

Group type: EXPERIMENTAL
Intervention: Systematic treatment of depression in elderly individuals
Number of subjects: 0

Group type: COMPARATOR
Intervention: Not available
Number of subjects: 0
Study: 15631968

Group type: EXPERIMENTAL
Intervention: Web-based nutrition counselling and social support (Heartweb)
Number of subjects: 146

Group type: COMPARATOR
Intervention: Usual care (Control)
Number of subjects: 146
Study: 11561262

Group type: EXPERIMENTAL
Intervention: Short impulse (0.1 ms)
Number of subjects: 87

Group type: COMPARATOR
Intervention: Long impulse (0.3 ms)
Number of subjects: 87

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 87
Study: 9626221

Group type: EXPERIMENTAL
Intervention: Radiotherapy and carmustine (BCNU)
Number of subjects: 701

Group type: COMPARATOR
Intervention: Radiotherapy and 1-(2-chloroethyl)-3(2,6 dioxo-l-piperidyl)-1-nitrosource a (PCNU)
Number of subjects: 701

Group type: COMPARATOR
Intervention: Radiotherapy and BCNU and interferon alfa (IFN)
Number of subjects: 701
Study: 7962332

Group type: EXPERIMENTAL
Intervention: Strict glycemic control in IDDM patients
Number of subjects: 28

Group type: COMPARATOR
Intervention: Cold pressor test
Number of subjects: 28

Group type: COMPARATOR
Intervention: Metyrapone test
Number of subjects: 28

Group type: COMPARATOR
Intervention: L-arginine infusion
Number of subjects: 28
Study: 3610511

Group type: EXPERIMENTAL
Intervention: Benzydamine hydrochloride pump spray
Number of subjects: 56

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 56
Study: 31418814

Group type: EXPERIMENTAL
Intervention: aP-containing vaccines
Number of subjects: 315

Group type: COMPARATOR
Intervention: wP-containing vaccines (control group)
Number of subjects: 315

Group type: EXPERIMENTAL
Intervention: wP-containing vaccines
Number of subjects: 315
Study: 29879947

Group type: EXPERIMENTAL
Intervention: Tranexamic acid
Number of subjects: 14923

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14923
Study: 27011177

Group type: EXPERIMENTAL
Intervention: Low frequency repetitive transcranial magnetic stimulation (rTMS) applied bilaterally over the sensory motor area for six weeks
Number of subjects: 22

Group type: COMPARATOR
Intervention: Placebo (SHAM)
Number of subjects: 22
Study: 25264610

Group type: EXPERIMENTAL
Intervention: Play on the school field
Number of subjects: 25

Group type: COMPARATOR
Intervention: Play on the playground
Number of subjects: 25
Study: 22916805

Group type: EXPERIMENTAL
Intervention: Pulse-based diet (two servings daily of beans, chickpeas, peas or lentils; about 150 g/d dry weight)
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: Pulse-based diet (in sub-analysis of individuals with high lipid levels)
Number of subjects: 108

Group type: COMPARATOR
Intervention: Regular diet
Number of subjects: 108
Study: 20165821

Group type: EXPERIMENTAL
Intervention: Metoclopramide injections
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Radiation treatment (RT)
Number of subjects: 16
Study: 18701691

Group type: EXPERIMENTAL
Intervention: Paired associative stimulation (PAS) at 8:00 P.M. after oral hydrocortisone (24 mg)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Paired associative stimulation (PAS) at 8:00 P.M. after placebo
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Oral hydrocortisone (24 mg)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Paired associative stimulation (PAS)
Number of subjects: 25
Study: 15914307

Group type: EXPERIMENTAL
Intervention: Wrist restraint behind the body whilst seated
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Wrist restraint in front of the body whilst seated
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Lying prone with wrists restrained behind back
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Lying prone with arms free
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Lying supine with wrists restrained in front
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Seated position with wrists restrained behind the back
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Prone position with wrist restraint
Number of subjects: 8
Study: 11929139

Group type: EXPERIMENTAL
Intervention: Laparoscopic TCI
Number of subjects: 42

Group type: COMPARATOR
Intervention: Conventional TCI
Number of subjects: 42
Study: 10951799

Group type: COMPARATOR
Intervention: Fentanyl (50 ug) added to 20 ml of 0.125% bupivacaine
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Ketamine (50 mg) added to 20 ml of 0.125% bupivacaine
Number of subjects: 40
Study: 7740948

Group type: EXPERIMENTAL
Intervention: Administration of cephalosporins 20 minutes before tourniquet inflation
Number of subjects: 62
Study: 1492140

Group type: EXPERIMENTAL
Intervention: Dexamethasone suppression test (DST)
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Depressive attributional style questionnaire (ASQ)
Number of subjects: 105

Group type: COMPARATOR
Intervention: Normal controls (ASQ)
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: ASQ scores
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: ASQ bad event attributions
Number of subjects: 105
Study: 3699962

Group type: EXPERIMENTAL
Intervention: Benzoic acid
Number of subjects: 258

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 258

Group type: EXPERIMENTAL
Intervention: Active substances (including butylhydroxytoluene, butylhydroxyanisole, beta‐carotene, beta‐8‐apo‐carotenal, sodium metabisulfite)
Number of subjects: 258
Study: 31549899

Group type: EXPERIMENTAL
Intervention: HRIG (KEDRAB) 20 IU/kg
Number of subjects: 118

Group type: COMPARATOR
Intervention: Comparator (HyperRAB S/D®)
Number of subjects: 118

Group type: EXPERIMENTAL
Intervention: HRIG (KEDRAB)
Number of subjects: 118
Study: 28975432

Group type: EXPERIMENTAL
Intervention: Fortified milk (1200 mg calcium, 96 mg magnesium, 2.4 mg zinc, 15 μg vitamin D, 4 g FOS-inulin per day)
Number of subjects: 121

Group type: COMPARATOR
Intervention: Regular milk (428 mg calcium per day)
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: Fortified milk
Number of subjects: 121

Group type: COMPARATOR
Intervention: Regular milk
Number of subjects: 121
Study: 26374911

Group type: EXPERIMENTAL
Intervention: hIVIG (0.25 g/kg)
Number of subjects: 31
Study: 25934631

Group type: EXPERIMENTAL
Intervention: Dietary nitrate supplementation as beetroot juice (4.8 mmol twice a day for 3 days)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Placebo (nitrate deplete beetroot juice)
Number of subjects: 35
Study: 23632980

Group type: EXPERIMENTAL
Intervention: Carotid endarterectomy and appropriate medication
Number of subjects: 2707
Study: 21823171

Group type: EXPERIMENTAL
Intervention: Clinical Trial (CT) - buprenorphine
Number of subjects: 114

Group type: EXPERIMENTAL
Intervention: Clinical Trial (CT) - methadone
Number of subjects: 114

Group type: COMPARATOR
Intervention: Structured Protocol (SP) - buprenorphine
Number of subjects: 114

Group type: COMPARATOR
Intervention: Structured Protocol (SP) - methadone
Number of subjects: 114
Study: 18290977

Group type: EXPERIMENTAL
Intervention: Network-based rehabilitation programme (n=343)
Number of subjects: 708

Group type: COMPARATOR
Intervention: Standard health and social services (Control group, n=365)
Number of subjects: 708
Study: 16787802

Group type: EXPERIMENTAL
Intervention: Multiple-dose activated charcoal (G1)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Simple dose of 1 g/kg activated charcoal (G2)
Number of subjects: 12
Study: 14616409

Group type: EXPERIMENTAL
Intervention: Voriconazole with food
Number of subjects: 12

Group type: COMPARATOR
Intervention: Voriconazole in fasted state
Number of subjects: 12
Study: 10741624

Group type: EXPERIMENTAL
Intervention: Cimetidine (800 mg)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Probenecid (1,500 mg)
Number of subjects: 9
Study: 7756094

Group type: EXPERIMENTAL
Intervention: Feedback-controlled infusions of omeprazole (target pH 5, dose range 0-12 mg h-1) with an initial bolus of 80 mg
Number of subjects: 16

Group type: COMPARATOR
Intervention: Fixed-dose infusions of omeprazole (8 mg h-1) with an initial bolus of 80 mg
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Initial bolus of 40 mg omeprazole followed by feedback-controlled infusions
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Initial bolus of 80 mg omeprazole followed by feedback-controlled infusions
Number of subjects: 16
Study: 2280336

Group type: EXPERIMENTAL
Intervention: Hoblitzelle Adapted Shame and Guilt Scale (ASGS)
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Harder Personal Feelings Questionnaire (PFQ2)
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: New scales constructed from factor analyses and item analyses
Number of subjects: 63
Study: 6155203

Group type: COMPARATOR
Intervention: Combination of bleomycin and adriamycin (chemotherapy)
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Combination of bleomycin and adriamycin with radiation (3600-4000 rad)
Number of subjects: 31
Study: 30877271

Group type: EXPERIMENTAL
Intervention: Citalopram infusion in MDD patients
Number of subjects: 77

Group type: EXPERIMENTAL
Intervention: Citalopram infusion in healthy controls
Number of subjects: 77

Group type: COMPARATOR
Intervention: Saline infusion in MDD patients
Number of subjects: 77

Group type: COMPARATOR
Intervention: Saline infusion in healthy controls
Number of subjects: 77

Group type: EXPERIMENTAL
Intervention: Greater rumination self-ratings in MDD group
Number of subjects: 77
Study: 28540894

Group type: EXPERIMENTAL
Intervention: Hydrochlorothiazide (HCTZ) 1 mg/kg/day for 3 months
Number of subjects: 88

Group type: COMPARATOR
Intervention: Control group (training without intervention)
Number of subjects: 88
Study: 25296401

Group type: EXPERIMENTAL
Intervention: VR training (12 simulated slips using visual perturbation induced by tilting a VR scene while walking on the treadmill)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: VR training
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control (normal walking during the training session)
Number of subjects: 24
Study: 23149239

Group type: EXPERIMENTAL
Intervention: Counselling (PRIME), n=16
Number of subjects: 33

Group type: COMPARATOR
Intervention: Active control (Parenting support), n=12
Number of subjects: 33

Group type: COMPARATOR
Intervention: Matched control (standard care), n=5
Number of subjects: 33
Study: 21729686

Group type: EXPERIMENTAL
Intervention: AEG35156 (650 mg) in combination with high-dose cytarabine and idarubicin
Number of subjects: 27

Group type: COMPARATOR
Intervention: High-dose cytarabine and idarubicin alone
Number of subjects: 27
Study: 19192840

Group type: EXPERIMENTAL
Intervention: 15% carbamide peroxide gel (bleaching group)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Control group (deionized water)
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Filtek Z350 and P60 (bleaching group)
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Dyract AP (bleaching group)
Number of subjects: 34
Study: 16983592

Group type: EXPERIMENTAL
Intervention: Neoadjuvant 8-week dose-dense doxorubicin plus docetaxel
Number of subjects: 607

Group type: COMPARATOR
Intervention: 24-week schedule of doxorubicin plus cyclophosphamide followed by docetaxel (AC-DOC)
Number of subjects: 607
Study: 12734908

Group type: EXPERIMENTAL
Intervention: Sodium oxybate (6.0 g/day)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 11061657

Group type: COMPARATOR
Intervention: Standard recommendation of 200 mg daily during the first 2 weeks (n = 166)
Number of subjects: 469

Group type: EXPERIMENTAL
Intervention: Prednisone 50 mg every other day during the first 2 weeks (n = 93)
Number of subjects: 469

Group type: EXPERIMENTAL
Intervention: Slowly escalating dose starting with 100 mg daily (n = 107)
Number of subjects: 469

Group type: EXPERIMENTAL
Intervention: Combination of prednisone and slowly escalating dose (n = 103)
Number of subjects: 469

Group type: EXPERIMENTAL
Intervention: New approaches (including prednisone and slowly escalating dose)
Number of subjects: 469
Study: 9077371

Group type: EXPERIMENTAL
Intervention: IGF‐I [8 micrograms kg‐1 h‐1] by continuous subcutaneous infusion
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: GH (6 U. twice daily s.c.) for 5 days
Number of subjects: 7

Group type: COMPARATOR
Intervention: Saline 0.9% (S)
Number of subjects: 7
Study: 7951761

Group type: EXPERIMENTAL
Intervention: Peanut oil in milk formulas
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: Elimination of peanut oil from milk formulas
Number of subjects: 4
Study: 2444166

Group type: EXPERIMENTAL
Intervention: 1% lindane shampoo for four minutes
Number of subjects: 53

Group type: COMPARATOR
Intervention: 1% permethrin creme rinse for ten minutes
Number of subjects: 53
Study: 29762273

Group type: EXPERIMENTAL
Intervention: Practices with high patient-centered cultures
Number of subjects: 606

Group type: EXPERIMENTAL
Intervention: More activated patients
Number of subjects: 606
Study: 28443338

Group type: EXPERIMENTAL
Intervention: Consultation with a certified child passenger safety (CPS) technician
Number of subjects: 189

Group type: COMPARATOR
Intervention: Standard care with CSS safety brochure
Number of subjects: 189
Study: 26290867

Group type: EXPERIMENTAL
Intervention: LC n‐3 PUFAs (2.52 g/day)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo (canola oil)
Number of subjects: 0
Study: 24385636

Group type: EXPERIMENTAL
Intervention: Memory training
Number of subjects: 1912

Group type: EXPERIMENTAL
Intervention: Booster-memory training
Number of subjects: 1912

Group type: COMPARATOR
Intervention: No-contact Control group
Number of subjects: 1912
Study: 20840564

Group type: EXPERIMENTAL
Intervention: Side-lying hip abduction training with external loading (10 repetition maximum)
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Side-lying hip abduction training without external loading (weight of the leg)
Number of subjects: 31
Study: 18424600

Group type: EXPERIMENTAL
Intervention: Full-dose almonds (73 +/- 3 g/d)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Half-dose almonds plus half-dose muffins
Number of subjects: 27

Group type: COMPARATOR
Intervention: Full-dose muffins (control)
Number of subjects: 27
Study: 16644224

Group type: EXPERIMENTAL
Intervention: ACI‐C (type I/III collagen membrane)
Number of subjects: 68

Group type: COMPARATOR
Intervention: ACI‐P (periosteal cover)
Number of subjects: 68
Study: 12600847

Group type: EXPERIMENTAL
Intervention: Lean beef diet
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Lean fish diet
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Poultry diet
Number of subjects: 0
Study: 10839090

Group type: EXPERIMENTAL
Intervention: Nimbus III APMRS (Huntleigh Healthcare Ltd)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Control surfaces (mainly APMRS; Pegasus Airwave, Pegasus Egerton in hospital; AlphaXcell, Huntleigh Healthcare Ltd in residential care)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Control surfaces
Number of subjects: 32
Study: 8780944

Group type: EXPERIMENTAL
Intervention: Thymostimulin (TP1) at dosages of 0.5 mg/kg, 1.0 mg/kg, and 2.0 mg/kg body weight
Number of subjects: 34

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 34

Group type: COMPARATOR
Intervention: No treatment (untreated group)
Number of subjects: 34
Study: 1623900

Group type: EXPERIMENTAL
Intervention: dexfenfluramine (30 mg daily)
Number of subjects: 30

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 30
Study: 6597721

Group type: EXPERIMENTAL
Intervention: Indometacin (3 X 50 mg daily)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Carprofen (2 X 150 mg daily)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Placebo (3 X daily)
Number of subjects: 9
Study: 31315700

Group type: EXPERIMENTAL
Intervention: Stepwise measures to ensure sputum quality (instructions by a study nurse, sputum induction if necessary)
Number of subjects: 980

Group type: COMPARATOR
Intervention: Standard sputum collection without observation (control group)
Number of subjects: 980
Study: 29299957

Group type: EXPERIMENTAL
Intervention: Cancer Home-Life Intervention
Number of subjects: 242

Group type: COMPARATOR
Intervention: Usual care (Control)
Number of subjects: 242
Study: 26954267

Group type: EXPERIMENTAL
Intervention: JASP+EMT+SGD
Number of subjects: 61

Group type: COMPARATOR
Intervention: JASP+EMT
Number of subjects: 61
Study: 25387780

Group type: EXPERIMENTAL
Intervention: Rhythm control
Number of subjects: 2439

Group type: COMPARATOR
Intervention: Rate control
Number of subjects: 2439
Study: 22252798

Group type: EXPERIMENTAL
Intervention: Telavancin
Number of subjects: 0
Study: 19337933

Group type: EXPERIMENTAL
Intervention: Neuropsychological intervention 1
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Neuropsychological intervention 2
Number of subjects: 96

Group type: COMPARATOR
Intervention: Control group (no specific training)
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Overall neuropsychological test results
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Clinically relevant neuropsychological deficits
Number of subjects: 96
Study: 17717679

Group type: EXPERIMENTAL
Intervention: Fly-wheel ergometer (FWE)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Standard knee extensor training equipment
Number of subjects: 29
Study: 15105030

Group type: EXPERIMENTAL
Intervention: Tamarind supplementation for 3 weeks
Number of subjects: 30

Group type: COMPARATOR
Intervention: Defluoridated water (control) for 3 weeks
Number of subjects: 30
Study: 12470198

Group type: EXPERIMENTAL
Intervention: Vitamin E supplementation (400 mg/day for 6 weeks)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study: 9814508

Group type: EXPERIMENTAL
Intervention: FSH 200 IU
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: FSH 100 IU
Number of subjects: 16

Group type: COMPARATOR
Intervention: Control (saline)
Number of subjects: 16
Study: 7808991

Group type: EXPERIMENTAL
Intervention: Four months Rifampin (A)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Two months Rifampin plus Pyrazinamide (B)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Six months Isoniacid (C)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Overall compliance across all groups
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Overall adverse effects across all groups
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Group B (Two months Rifampin plus Pyrazinamide)
Number of subjects: 150
Study: 2782269

Group type: EXPERIMENTAL
Intervention: Propranolol + Nifedipine (10 or 20 mg every 8 hours)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Propranolol + Diltiazem (60 or 120 mg every 8 hours)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Propranolol + Nifedipine
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Propranolol + Diltiazem
Number of subjects: 12
Study: 31402234

Group type: EXPERIMENTAL
Intervention: PC appointment booked through the booking website prior to ED discharge
Number of subjects: 272

Group type: EXPERIMENTAL
Intervention: Written information on how to use the booking website
Number of subjects: 272

Group type: COMPARATOR
Intervention: Usual care (standard follow-up instructions)
Number of subjects: 272
Study: 31080087

Group type: EXPERIMENTAL
Intervention: 3D-laparoscopy
Number of subjects: 40

Group type: COMPARATOR
Intervention: 2D-laparoscopy
Number of subjects: 40
Study: 28422861

Group type: EXPERIMENTAL
Intervention: Infliximab (IFX)
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Adalimumab (ADA)
Number of subjects: 68

Group type: COMPARATOR
Intervention: C-reactive protein (CRP) at biologic introduction
Number of subjects: 68

Group type: COMPARATOR
Intervention: Age at CD onset
Number of subjects: 68
Study: 26718434

Group type: EXPERIMENTAL
Intervention: Autologous endometrial cells coculture (AECC)
Number of subjects: 339

Group type: COMPARATOR
Intervention: Control group (transfer of one embryo on day 3)
Number of subjects: 339
Study: 23319447

Group type: EXPERIMENTAL
Intervention: High-fat diet (15.4 g of fat)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Low-fat diet (4.0 g of fat)
Number of subjects: 9
Study: 21422304

Group type: EXPERIMENTAL
Intervention: Low-frequency (1-Hz) 110% motor threshold rTMS to the left temporoparietal junction for 2 weeks
Number of subjects: 14

Group type: COMPARATOR
Intervention: Sham treatment to the left temporoparietal junction for 2 weeks
Number of subjects: 14

Group type: COMPARATOR
Intervention: Comparison of active rTMS vs sham treatment
Number of subjects: 14
Study: 19186908

Group type: EXPERIMENTAL
Intervention: Leader prototypicality
Number of subjects: 0

Group type: COMPARATOR
Intervention: Procedural fairness (voice)
Number of subjects: 0
Study: 16923629

Group type: EXPERIMENTAL
Intervention: Parent-held child health record (PHCHR)
Number of subjects: 309
Study: 15207063

Group type: EXPERIMENTAL
Intervention: Respiratory syncytial virus (RSV)
Number of subjects: 293

Group type: EXPERIMENTAL
Intervention: Enteroviruses
Number of subjects: 293

Group type: EXPERIMENTAL
Intervention: Rhinovirus
Number of subjects: 293

Group type: EXPERIMENTAL
Intervention: Nontypable rhino/enterovirus
Number of subjects: 293

Group type: EXPERIMENTAL
Intervention: Respiratory picornaviruses (rhinovirus and enteroviruses)
Number of subjects: 293

Group type: EXPERIMENTAL
Intervention: Human metapneumovirus
Number of subjects: 293
Study: 11469927

Group type: EXPERIMENTAL
Intervention: Tamoxifen 20 mg/day
Number of subjects: 22000

Group type: COMPARATOR
Intervention: Raloxifene 60 mg/day
Number of subjects: 22000

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22000
Study: 9207358

Group type: EXPERIMENTAL
Intervention: MAC disease (cases)
Number of subjects: 571

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 571
Study: 8133561

Group type: EXPERIMENTAL
Intervention: Rice-based ORS (50 g/l)
Number of subjects: 148

Group type: COMPARATOR
Intervention: Glucose ORS
Number of subjects: 148

Group type: EXPERIMENTAL
Intervention: Rice-based ORS
Number of subjects: 148